REGN Snapshot
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Market Capitalization$66,473,402,000
Price to Sales4.98
Earnings per Share$62.5300
PE Ratio9.89
Most Recent Close$614.3800
52 Week High$686.62
52 Week Low$441
50-Day Moving Average$632.77
200-Day Moving Average$584.01
All data are from Alpha Vantage as of today. For more infomation on REGN see Stock Dividend, Valuation, Price and Financial Data for Investors